An open-label randomized controlled trial to evaluate the efficacy of antihistamine premedication and infusion prolongation in prevention of hypersensitivity reaction to oxaliplatin.
A Pilot Randomized Controlled Trial of the Addition of Curcumin Mouthwash in Coconut Oil Solvent Compared with Normal Saline Solution for Preventing and Relieving Oral Mucositis in Locally Advanced Head and Neck Cancer Patients Who Undergoing Concurrent Chemoradiotherapy
A Prospective study to compare the efficacy between povidone-iodine gargling and benzydamine hydrochloride (Difflam®) for mucositis prevention from chemoradiotherapy in head and neck cancers, preliminary analysis.
Change in Ki67 Between Pre- and Post-neoadjuvant Chemotherapy as a Prognostic Marker in Localized Triple-negative Breast Cancer Patients
Clinical Treatment Score post-5 years (CTS5) as a Tool for Risk Estimation of Late Recurrence in Thai Patients with Estrogen Receptor Positive, Early Breast Cancer : A Validation study
Association of MCM2 expression and RCB 0/I in hormonal receptor positive HER2 negative early breast cancer patients receiving neoadjuvant chemotherapy
Gut Microbiome Profile and Clinical Correlations in Advanced EGFR-WT and EGFR-Mutant Non-Small Cell Lung Cancer
Factors Associated with Occurrence of T790M Secondary EGFR Mutation in Patient with Advanced EGFR-mutant Non-small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitor
The Benefits of G8 and VES-13 Geriatric Screening Tools for Elderly Patients with Advanced Lung Cancer
The effect of primary tumor location on second- or later-line treatment with anti- EGFR antibodies in patients with metastatic colorectal cancer: A single-center cohort study
Molecular Alterations, Tumor Microenvironment and Clinical Correlationsin Thai Cholangiocarcinoma Patients
Expression of Cannabinoids receptor 1 in Cholangiocarcinoma
A Comparative study on the effect of palliative care between palliative care team and medical oncologists in patients with advanced cancer at Phramongkutklao hospital
A double-blind, placebo-controlled randomized trial phase IIa, evaluating the effect of curcumin for the treatment of cancer anorexia-cachexia syndrome in patients with stage III-IV of head and neck cancer (CurChexia)